Join Index
For Startups
For Investors
For Brands
For Analysts
Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Expert
Innovation Services
About Index
Index
By TNW
Log in
Register
Syntimmune
4222
Syntimmune
Health Care
Technology
Biotechnology
Medical
Pharmaceuticals
Founded in 2013, Syntimmune is the worlds leader in the biology of the neonatal Fc receptor (FcRn). Syntimmune's lead program targets FcRn.
Suggest edits
Founded
2013
Raised
$84M
Follow us
Also headquartered in New York
Verizon
IBM
HBO
Kickstarter
Wired
Goldman Sachs
Bloomberg
JPMorgan
Time Warner
The New York Times
Companies in the same industry
Atlantic Healthcare plc
Prometic
Tricida, Inc.
Oculis
Sensulin
Credence MedSystems
Premier Research
Moirai BioDesign
TearSolutions
Strongbridge Biopharma
Alexa global traffic share
